210 related articles for article (PubMed ID: 17202157)
1. DNA methylation immediately adjacent to active histone marking does not silence transcription.
Brinkman AB; Pennings SW; Braliou GG; Rietveld LE; Stunnenberg HG
Nucleic Acids Res; 2007; 35(3):801-11. PubMed ID: 17202157
[TBL] [Abstract][Full Text] [Related]
2. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
Zhang Y; Fatima N; Dufau ML
Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
[TBL] [Abstract][Full Text] [Related]
3. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of CIITA expression in human T-cells.
van Eggermond MC; Boom DR; Klous P; Schooten E; Marquez VE; Wierda RJ; Holling TM; van den Elsen PJ
Biochem Pharmacol; 2011 Nov; 82(10):1430-7. PubMed ID: 21664896
[TBL] [Abstract][Full Text] [Related]
5. Positive histone marks are associated with active transcription from a methylated ICSBP/IRF8 gene.
Tshuikina M; Nilsson K; Oberg F
Gene; 2008 Mar; 410(2):259-67. PubMed ID: 18242011
[TBL] [Abstract][Full Text] [Related]
6. Tissue-specific and imprinted epigenetic modifications of the human NDN gene.
Lau JC; Hanel ML; Wevrick R
Nucleic Acids Res; 2004; 32(11):3376-82. PubMed ID: 15247330
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic mechanism of rRNA gene silencing: temporal order of NoRC-mediated histone modification, chromatin remodeling, and DNA methylation.
Santoro R; Grummt I
Mol Cell Biol; 2005 Apr; 25(7):2539-46. PubMed ID: 15767661
[TBL] [Abstract][Full Text] [Related]
8. In vivo repression of an erythroid-specific gene by distinct corepressor complexes.
Rietveld LE; Caldenhoven E; Stunnenberg HG
EMBO J; 2002 Mar; 21(6):1389-97. PubMed ID: 11889044
[TBL] [Abstract][Full Text] [Related]
9. Regulation of transcription of the steroidogenic acute regulatory protein (StAR) gene: temporal and spatial changes in transcription factor binding and histone modification.
Hiroi H; Christenson LK; Strauss JF
Mol Cell Endocrinol; 2004 Feb; 215(1-2):119-26. PubMed ID: 15026184
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic control of ovarian function: the emerging role of histone modifications.
LaVoie HA
Mol Cell Endocrinol; 2005 Nov; 243(1-2):12-8. PubMed ID: 16219412
[TBL] [Abstract][Full Text] [Related]
11. Novel relationships among DNA methylation, histone modifications and gene expression in Ascobolus.
Barra JL; Holmes AM; Grégoire A; Rossignol JL; Faugeron G
Mol Microbiol; 2005 Jul; 57(1):180-95. PubMed ID: 15948959
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic interplay between histone modifications and DNA methylation in gene silencing.
Vaissière T; Sawan C; Herceg Z
Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786
[TBL] [Abstract][Full Text] [Related]
13. Promoter-restricted histone code, not the differentially methylated DNA regions or antisense transcripts, marks the imprinting status of IGF2R in human and mouse.
Vu TH; Li T; Hoffman AR
Hum Mol Genet; 2004 Oct; 13(19):2233-45. PubMed ID: 15294879
[TBL] [Abstract][Full Text] [Related]
14. Developmental changes in DNA methylation and covalent histone modifications of chromatin associated with the epsilon-, gamma-, and beta-globin gene promoters in Papio anubis.
Lavelle D; Vaitkus K; Hankewych M; Singh M; DeSimone J
Blood Cells Mol Dis; 2006; 36(2):269-78. PubMed ID: 16527500
[TBL] [Abstract][Full Text] [Related]
15. Nucleosomes at active promoters: unforgettable loss.
Henikoff S
Cancer Cell; 2007 Nov; 12(5):407-9. PubMed ID: 17996642
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic changes in solid and hematopoietic tumors.
Toyota M; Issa JP
Semin Oncol; 2005 Oct; 32(5):521-30. PubMed ID: 16210093
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid receptor beta2 is epigenetically silenced either by DNA methylation or repressive histone modifications at the promoter in cervical cancer cells.
Zhang Z; Joh K; Yatsuki H; Zhao W; Soejima H; Higashimoto K; Noguchi M; Yokoyama M; Iwasaka T; Mukai T
Cancer Lett; 2007 Mar; 247(2):318-27. PubMed ID: 16806674
[TBL] [Abstract][Full Text] [Related]
18. Stability of histone modifications across mammalian genomes: implications for 'epigenetic' marking.
Lee BM; Mahadevan LC
J Cell Biochem; 2009 Sep; 108(1):22-34. PubMed ID: 19623574
[TBL] [Abstract][Full Text] [Related]
19. Uteroplacental insufficiency affects epigenetic determinants of chromatin structure in brains of neonatal and juvenile IUGR rats.
Ke X; Lei Q; James SJ; Kelleher SL; Melnyk S; Jernigan S; Yu X; Wang L; Callaway CW; Gill G; Chan GM; Albertine KH; McKnight RA; Lane RH
Physiol Genomics; 2006 Mar; 25(1):16-28. PubMed ID: 16380407
[TBL] [Abstract][Full Text] [Related]
20. Plakoglobin is differentially expressed in alveolar and embryonal rhabdomyosarcoma and is regulated by DNA methylation and histone acetylation.
Gastaldi T; Bonvini P; Sartori F; Marrone A; Iolascon A; Rosolen A
Carcinogenesis; 2006 Sep; 27(9):1758-67. PubMed ID: 16537559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
